Genetic Testing Market Share, Growth Rate, Sales Value and Industrial Production 2027

Genetic Testing Market Overview

As per the assessment conducted by Market Research Future (MRFR), the global market for the genetic testing market is estimated to garner a market value of USD 30.10 Billion while thriving at a CAGR of 10.30% by 2027. Genetic testing is used in prenatal screening, diagnostics, and as a predictive tool.

The on-going technical development in genetic testing is anticipated to play a significant role in developing the global genetic testing market during the forecast period. The rising demand for genetic testing in oncology and the increasing adoption of genetic tests into clinical care is another salient factor that can drive the regional market. Furthermore, the growing demand for personalized medicine can be recognized a crucial factor that can augment the market size in the assessment timeframe. On the contrary, lack of expertise in developing and underdeveloped countries is expected to hamper the market growth. In addition, the high expenses associated with genetic testing is likely to affect the adoption rate and inhibit the market rise.

The outbreak of COVID-19 is likely to bring a negative impact on the market growth due to the temporary shutdown of testing labs and clinics, which brought a negative impact on the market.

Genetic Testing Market Segmentation

The global market for the genetic testing market can be segmented into method, type, and application.

The method-based segments of the global genetic testing market are molecular genetic tests/ DNA tests, chromosomal genetic tests, and biochemical, genetic tests. Among all, the molecular genetic test/DNA tests is anticipated to procure a market share of 11.78% during the review time.

The type-based segments of the global genetic testing market are prescribed genetic testing and direct to consumer genetic testing. Among all, the prescribed genetic testing is anticipated to procure a major market share while expanding at the highest CAGR by 2024.

Get customized Sample with complete Toc, Inclusive of COVID-19 Industry Analysis @

The application-based segments of the global genetic testing market are reproductive health, cancer screening, ancestry, predictive and pre-symptomatic testing, and others. Among all, the reproductive health segment is anticipated to lead the segment in the assessment tenure.

Genetic Testing Market Regional Analysis

As per the assessment conducted by MRFR, the Americas is anticipated to lead the global market during the forecast period. The region is expected to thrive at the maximum CAGR in the coming time. The increasing demand for personalized genetic testing and the favorable initiatives taken by the government are other salient causes that can grow the market in the coming time. APAC is anticipated to be the fastest-growing region during the review time. The increasing adoption of a sedentary lifestyle and the growing consumption of junk food is likely to play a salient role in driving the regional market in the assessment tenure. Developing countries such as; India and China are anticipated to make a notable contribution in developing the industry in the coming time. On the other hand, MEA is likely to witness the growing adoption of technology and increased government initiatives that can improve the healthcare infrastructure. In addition, the increasing prevalence of metabolic diseases in the region is likely to increase the demand for genetic testing and augment the market share of the region.

Genetic Testing Market Key Players

Some of the renowned players of the global genetic testing market are Blueprint Genetics (Finland), Bio-Rad Laboratories, Inc. (US), PerkinElmer Inc. (US), Myriad Genetics, Inc. (US), Illumina Inc. (US),  QIAGEN N. V.  (Germany), Eurofins Scientific (US), F. Hoffmann-La Roche Ltd (Switzerland), Abbott Laboratories (US), Quest Diagnostics Incorporated (US), BGI Genomics (China), and Thermo Fisher Scientific Inc. (US).

Genetic Testing Industry News

February 2021- Seneca Therapeutics has expanded its R&D pipeline to include six new armed gene therapy/oncolytic constructs directed against important cancer targets and indications.

February 2021– Scientists in Beijing have developed a new gene therapy that can reverse some of the effects of aging in mice and increase their lifespans. The therapy can be fruitful for humans in the future.

February 2021- Taysha Gene Therapies, a patient-centric, clinical-stage gene therapy company, which is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS, announced their collaborations with Cleveland Clinic and UT Southwestern Gene Therapy Program (UTSW_ to advance next-generation mini-gene payloads for AAV gene therapies for the treatment of genetic epilepsies and additional CNS disorders.

February 2021– Paragon Biosciences, a life science innovator, and cell and gene therapy and synthetic biology utilizing AI, has launched CiRC Biosciences, a cell therapy company, developing a treatment for severe diseases with an initial focus on the eye.

Get Premium Research Report, Inclusive of COVID-19 Impact Analysis, Find more information @

COVID-19 Sample Collection Kits Market Analysis, Growth by Top Companies, Trends by Application, Forecast – 2027

COVID-19 Sample Collection Kits Market Overview

Global COVID-19 Sample Collection Kits Market is slated to acquire a value of USD 4.16 billion by 2027 and is slated to register a growth of 5.20% over the review period of 2020 to 2027.

COVID-19 Sample Collection Kits Market Dynamics

The COVID-19 outbreak has resulted in a surge in demand for the COVID-19 sample collection package. The vitals and reagents given for collecting samples and shipping them to the laboratory where the research services will be conducted on such a sample are referred to as the sample collection kit. The high demand for sample collection kits as a result of the global outbreak of COVID-19, as well as government approval of new and advanced detection tests, are expected to drive COVID-19 Sample Collection Kits Market growth. Furthermore, an increase in antibody detection, an increase in government support, and a large volume of products and swab use rate are expected to drive market growth during the forecast period. The rising number of corona virus patients around the world, the the prevalence of the geriatric population, the levels of funds and investment for the development of medicines and advanced machines for virus testing and diagnosis, and various mergers and collaborations to increase the production of sample test kits are some of the major and important factors.

Everlywell, Inc. received an emergency use authorization (EUA) from the Food and Drug Administration (FDA) in May 2020 for the COVID-19 Test Home Collection Kit. The product is a nasal swab sample collection kit that can be used at home and sent to specific laboratories for COVID-19 diagnostic testing. As a result, demand for sample collection kits is increasing. Furthermore, the identification of antibodies, increased government funding, large volume of goods, and high swab use rate are expected to drive market growth.

However, a lack of laboratory-based reagents and a shortage of test-related supplies such as reverse transcription-polymerase chain reaction tools, swabs, and virus control samples to control COVID-19 are expected to limit the global COVID-19 sample collection kits market’s development.

Get Free Sample of This Report at:

COVID-19 Sample Collection Kits Market Segmental Analysis

The global COVID-19 sample collection kits market has been segmented based on the product type, application, and end user.

The market has been divided into swabs, viral transport media, blood collection kits, and others based on product type. The swabs segment is expected to rise at the fastest rate. Swabs are classified into two types: nasopharyngeal swabs and oropharyngeal swabs. Just nasopharyngeal swabs should be collected for research, according to the Centers for Disease Control and Prevention (CDC). The fastest-growing category is viral transportation media.

The market has been divided into diagnostic and analysis segments based on application. The diagnostic segment is expected to grow at the fastest rate, while the analysis segment is expected to grow at the fastest rate.

The market has been divided into hospitals and clinics, diagnostics centers, and others depending on the end consumer. The diagnostic center is expected to develop at the fastest pace. Hospitals and clinics are the fastest growing sector.

COVID-19 Sample Collection Kits Market Regional Analysis

Laboratory Corporation of America (LabCorp) is the first diagnostic test manufacturer for COVID-19 at-home specimen collection kit, according to the US Food and Drug Administration (FDA) in April 2020. During the forecast period, this is anticipated due to the high demand for sample collection kits across the country.

According to the MRFR, 2, 95,889 COVID-19 cases have been confirmed in the United Kingdom. Furthermore, the World Health Organization (WHO) and the European Centre for Disease Prevention and Control (ECDC) moved quickly to establish laboratory needs and capacities in the European region, according to the World Health Organization (WHO) and the European Centre for Disease Prevention and Control (ECDC) January 2020 study. As a result of an increase in the number of confirmed cases of COVID-19, sample collection kits are needed for laboratory tests and detection, which is expected to drive market development.

Because of the COVID-19 outbreak, the Asian Development Bank (ADB) announced a USD 6.5 billion assistance package for the Asia-Pacific region in March 2020. As a result, industry growth is projected to be fueled by increased government support.

The Middle East and Africa area is more in need of infrastructure growth and technological innovation. This results in a lack of growth in the healthcare sector, resulting in a decrease in sample collection kit demand on the market. To resolve this, market growth is expected to be fueled by advancements in development and technology.

Browse Full Report with TOC at:

COVID-19 Sample Collection Kits Market Competitive Analysis

The major players of the market are Thermo Fisher Scientific, Inc. (US), Hardy Diagnostics (US), BNTX Inc. (Germany), Formlabs (US), Medline Industries, Inc. (US), HiMedia Laboratories (India), VIRCELL S.L. (Spain), Puritan Medical Products (US), COPAN Diagnostics (California), Becton, Dickinson, and Company (US), Laboratory Corporation of America Holdings (US), Lucence Diagnostics Pte Ltd. (California).

Structural Heart Devices Market 2021 Growth, COVID Impact, Trends Analysis Report 2027

Structural Heart Devices Market Scope

Market Research Future (MFRF) studied the global structural heart devices market 2021 for the analysis period till 2023. As per MRFR analysis, the structural heart devices market is expected to expand at 10.4% CAGR through the forecast tenure (from 2018 to 2023). By 2023, the structural heart devices market value is expected to touch number. 

Structural Heart Devices Market Drivers and Restrains

The surge in cases of congenital cardiac defects and the increase in need for effective diagnosis for the early detection of such disease can favor the expansion of structural heart device market in the near future. The rise in cases of atrial septal defect, paravalvular leak, ventricular septal defect, arterial or venous fistula, congenital heart disease, and patent foramen oval is creating the demand for minimally invasive techniques, which, in turn, can drive the need for structural heart devices. Thus, can prompt the market upsurge in the analysis tenure. The availability of advanced products, such as; disruptive technology assisted structural heart valves for treating patients can promote the market growth in the years to come. On the contrary, the high expense of structural device is expected to limit the adoption of such device that can restrain the market upsurge. 

Segment Analysis of Structural Heart Devices Market

The segment study of the global structural heart devices market is based on type, procedure, indication, and end-user.

The type-based segments of the structural heart device market are occludes and delivery systems, heart valve devices, annuloplasty rings, and accessories among other devices. The segment of heart valve devices consists surgical heart valves and transcatheter heart valves. The segment of surgical heart valves further studies mechanical heart valves and tissue heart valves. The increase in utility of transcatheter heart valves is expected to prompt the market growth.

The indication-based segments of the structural heart device market are valvular heart disease, congenital heart defects, and cardiomyopathy among others. The segment of valvular heart disease studies stenosis and regurgitation. The cardiomyopathy segment can rise at decent CAGR over the review period.

Get Free Sample of This Report at:

The procedure-based segments of the structural heart device market are repair procedures and Replacement Procedures. The segment of replacement procedures is SAVR procedures and TAVR procedures. The segment of the repair procedures is assessed for closure procedures, valvuloplasty, annuloplasty, and TMVR procedures. The increase in adoption of TMVR procedures is likely to garner high revenue in the years to come.

The end-users-based segments of the structural heart device market are ambulatory surgery centres, and hospitals among others. The segment of ambulatory surgery centres is likely to thrive in the evaluation period. 

Regional Analysis of Structural Heart Devices Market

In the Americas, the market of structural heart devices is expected to earn considerable revenue over the analysis tenure for several factors. Increase in rate of surgeries due to pathological conditions, such as; diabetes, and high blood pressure among others can contribute to the expansion of the regional market. Other factors, such as; rise in healthcare awareness, the adoption of disruptive technology, rise in medical tourism, and increase in disposable income can promote North America structural heart device market.

In Europe, the market of structural heart devices market is expected to garner high revenue by 2023. Out of other EU regions, Germany is expected to contribute significantly to the regional market are earn decent revenue by 2023. The upsurge of EU structural heart device market is likely to thrive owing to increase in expansion of elderly population and rise in number of people suffering from obesity and diabetes in this region.

In Asia Pacific region, the market of structural heart devices is likely to earn considerable revenue in the review period owing to the surge in cardiac problem patient population. The structural heart device market in all regions of APAC is anticipated to garner huge revenue in the near future. In the Middle East Asia and Africa, the structural heart device market is likely to expand at sluggish pace due to low per capita income and stringent government policies. 

Browse Full Report with TOC at:

Structural Heart Devices Market Key Players

Edwards Lifesciences Corporation (US), LivaNova plc (UK), Biomerics, ST. Jude Medical, Medtronic plc (Ireland), Abbott (US), Comed BV, Boston Scientific Corporation (US), JenaValve Technology, Inc., CardioKinetix, Endologix Inc. (US)., Cook Group Incorporated (US), and W. L. Gore & Associates, Inc. (US) are some reputed companies in the global structural heart devices market that are listed by MRFR in the report.

Healthcare Claims Management Market foreseen to grow exponentially over 2020 – 2027

Healthcare Claims Management Market Scope 

Market Research Future (MRFR) assessed the global healthcare claims management market 2021 over the study tenure till 2027. MRFR data suggests that the advent of new treatments and technologies offering delivery of quality healthcare services can cause the market of healthcare claims management market to rise at a healthy CAGR of around 5.37% in the study period. By 2027, the global healthcare claim management market is anticipated to garner decent revenue. 

Healthcare Claims Management Market Drivers and Restraints 

Managing healthcare claims processes comprises different tasks, such as; billing, organization, processing, filling, and updating medical claims that are related to treatment, diagnosis, and medication of patients. The increase in focus on delivering quality healthcare services and surge in the adoption of cloud-based technology and associated services are expected to promote the market rise in the study period. The integration of robust claims management solutions to prevent data breaches and protect confidentiality is observed as another factor that is expected to bolster the expansion of the market in the review tenure. On the contrary, lack of IT expertise in the healthcare domain are other factors that can restrain the upsurge of the Healthcare Claims Management Market

Healthcare Claims Management Market Segmentation 

The segment study of the global healthcare claims management market is based on component, end-user, and delivery mode type. 

The component-based segments of the healthcare claims management market are services and software. Rapid advancements in technology and high investment of software vendors in developing highly efficient healthcare claim management software solutions is expected to favor the market in the upcoming years. 

The delivery mode-based segments of the healthcare claims management market are cloud based and on-premise. The inclination towards cloud-based solutions of healthcare claim management is identified to prompt the market upsurge. 

The type-based segments of the healthcare claims management market are standalone and integrated. The high preference of integrated healthcare claim management solutions by different health insurance companies is likely to promote the market growth.  

The end-user-based segments of the healthcare claims management market are providers and healthcare payers. The increase in the number of healthcare players is anticipated to favor the market rise in the foreseeable future. 

Get Free Sample of This Report at:

Healthcare Claims Management Market Regional Analysis 

The market healthcare claim management in the Americas is likely to maintain its dominance over the forecast tenure. This is likely owing to innovative and new treatments and technologies that can benefit the market upsurge in the near future. The heavy cash inflow from various government agencies to boost healthcare IT infrastructure setup is expected to promote the establishment of numerous healthcare claims management providers which, in turn, can benefit the expansion of the Americas market in the years to come. As per the study of the National Health Expenditure Accounts (NHEA), U.S. healthcare spending is likely to increase by considerable revenue in the years to come. In Europe, the surge in the increasing investment for building and maintaining a robust healthcare infrastructure and promoting effective services can benefit the market in the near future. In Asia Pacific, the market of healthcare claims management is observed to hold high potential, which, in turn, can promote the rise of the market in the APAC. In addition, the existence of some top-notch companies in the worldwide healthcare claims management solutions market is likely to prompt the APAC healthcare claim management market by 2027. In addition, the proactive participation of governments in APAC for the  market growth counting on the introduction of several initiatives to spread awareness among people are likely to promote the market growth in the years to come. The market in the Middle East and Africa is expected to rise at moderate pace and secure the smallest share of the worldwide healthcare claims management market by 2027. Issues with healthcare IT solutions expense to impact MEA market. 

Healthcare Claims Management Market Key Players 

Oracle Corporation, Accenture plc., Allscripts Healthcare Solutions, Inc., IBM Corporation, Cognizant Technology Solutions Corporation and Genpact Limited, Infor Inc., Cerner Corporation, eClinicalWorks, McKesson Corporation, athenahealth, Inc., Optum, Inc., Conifer Health Solutions, Avaya Inc., and nThrive, Inc are some eminent players in the global healthcare claims management market that are listed by MRFR. 

Browse Full Report with TOC at:

The global market of healthcare claims management market is expected to gain decent revenue from top-notch market players across the world. The introduction of innovations by several players in the market and strategic collaborations among these players are observed to work in favor of the healthcare claims management market in the years to come.

Hematology Diagnostics Market 2020 – 2027 Global Analysis, Size, Share, Incredible Growth, Detailed Industry Analysis and Business Prospects

Hematology Diagnostics Market – Overview

The renewed emphasis on health and wellness has prompted an increased focus on blood-related disorders as well. Market reports connected with the healthcare industry have been presented by Market Research Future which makes reports on other industry verticals that aims to analyze the current market scenarios better.  The market is set to profit from the positive CAGR in the market during the forecast period.

The increased prevalence of blood-related disorders is motivating the expansion of the hematology diagnostics market. Moreover, the development in the detection and diagnostic methods has improved the growth of the market for hematology diagnostics. The increased involvement of genetic diseases in blood-related ailments is projected to fuel the development of the hematology diagnostic market in the coming years.

Hematology Diagnostics Market Segmental Analysis

The segmental analysis of the hematology diagnostics market is segmented on the basis of tests, product type, and end-user. By product type, the hematology diagnostics market is segmented into flow cytometers, and consumables. The tests segment is additionally segmented into leukemia/lymphoma phenotyping, hemoglobinopathy, anemia, hematology pathophysiology, complete blood count (CBC) and others. Based on end-users, the market is segmented into ambulatory surgical centers, diagnostic laboratories, hospitals and clinics, academic institutes and others. 

Get customized Sample with complete Toc, Inclusive of COVID-19 Industry Analysis @    

Hematology Diagnostics Market Regional Analysis

The regional analysis of the hematology diagnostics market states that the North American region dominates the market due to the mounting incidence of blood diseases. The presence of the primary market players within the region is influencing the market growth. Factors such as growing healthcare expenditure, technological improvements within the population are driving the market development in this region. The European region is the subsequent market contender in the global hematology diagnostics market due to the growing hematology research within this region. The growing hematology research and government initiatives within this region are influencing the development of the hematology diagnostic market in this region.

The Asia Pacific region was recognized as the quickest rising region for the hematology diagnostics market globally in 2017. The market is projected to observe considerable development due to the intensifying commonness of blood disorders and genetic diseases. The predisposition of individuals in the region to genetic disorders due to marriages to blood relatives or marrying within the same community, ethnicity, caste, etc. The Middle Eastern and African region controls the smallest stake in the hematology diagnostics market globally owing to the incidence of strict government policies and deprived economies. Though, the market is projected to observe growth owing to increased investments by private market players in the Middle East. Moreover, the increasing incidence of genetic blood disorders and expanding government initiatives to develop the healthcare sector within the region is expected to contribute to the market’s growth.

Hematology Diagnostics Market Competitive Analysis

The growth of the market is moving in a favorable direction due to new product launches or rising gross revenue of the players in the market. Significant reductions in administrative costs are inducing further expansion of the market. The vertical additions and product tactics of the market are boosting the potential of the market players. The development of a robust value chain is further motivating the development of the market. The strategic goals intended for the market are reinforced due to favorable product differentiation carried out by market competitors.  Increased adaptability of market players to new market trends and customers inclinations are lifting the growth curve of the market and will continue do so in the forecast period. The successful implementation of strategies is expected to motivate the market in the coming years.

Get Premium Research Report, Inclusive of COVID-19 Impact Analysis, Find more information @

The central contenders in the hematology diagnostics market globally are Ortho Clinical Diagnostics (US), Danaher (US), Siemens (Germany), Boule Diagnostics (Sweden), HORIBA (Japan), Abbott Laboratories (US), EKF Diagnostics (UK), Bio-Rad Laboratories (US), BioSystems (Spain), Sysmex (Japan), Diatron (Hungary), Nihon Kohden (Japan), Drew Scientific (US), Mindray (China), and Roche (Switzerland), and other.

Arrhythmia Monitoring Devices Market Analysis by SWOT, Investment, Future Growth, Segments, Application and Regional Forecasts, 2027 |

Arrhythmia Monitoring Devices Market Scope

Market Research Future (MRFR) claims that the arrhythmia monitoring devices market should progress at a rate of 6.44% from 2020 to 2027 (review period). The global market is also likely to USD 8,087.4 million by 2027.

Primary Boosters and Challenges

The COVID-19 outbreak has sent the arrhythmia monitoring devices market reeling with a number of challenges, in the form of travel bans and vulnerable supply chains. The lockdown has resulted in a huge demand-supply gap. There has been a sharp decline in the manufacturing rate across countries with the novel coronavirus causing the leading players huge losses. The relentless surge in the number of SARS-CoV-2 cases has been unfavorable for the business scenario, as economic conditions continue to deteriorate. Moreover, the healthcare industry is focusing mostly on bringing down these cases, which also works against the arrhythmia monitoring devices industry to some extent.

With that said, the arrhythmia monitoring devices industry has the potential to maintain a steady growth throughout the review timeframe, as telecardiology continues to gain traction. Mounting awareness regarding the host of benefits these devices offer, such as convenient monitoring, ease of use and portability also foster their adoption rate. Latest studies confirm that close to 20 percent of adults worldwide are most likely to experience several types of premature ventricular heartbeats. Another report reveals that over 850,000 Americans have to be hospitalized due to arrhythmia every year. These statistics have been soaring rapidly and therefore, raise the need for advanced equipment and tools that can ensure effective and continuous monitoring. Expanding elderly population, in tandem with introduction of new and more innovative cardiac management monitoring devices should foster the growth trajectory of the global market.

Emergence of smart cardiac monitors, heavy burden of heart ailments and the rise in FDA approvals can also translate into considerable revenue generation in the next couple of years. Besides, the heightened preference for cost-effective electrocardiogram devices, and firms spending generously on R&D activities to come up with systems with better features should also favor the global market in the following years. Players frequently make strategic moves such as production expansion, technical innovations, and acquisition to improve their market rankings. Companies are also working on leveraging the potential of artificial intelligence, IoT and big data by integrating these technologies into their devices, to enhance their appeal. 

Get Free Sample of This Report at:

Arrhythmia Monitoring Devices Market Segmentation

Top segments considered in the study of the arrhythmia monitoring devices market include device type, application, and end user.

Device types analyzed in the report include mobile cardiac telemetry (MCT) devices, resting ECG, implantable cardiac monitor (ICM), Holter monitor, event monitor, among others.

Conduction disorders, premature ventricular contractions (PVC), tachycardia, ventricular fibrillation (V-fib), bradycardia and atrial fibrillation (A-fib) are some of the major applications covered in the report.

Home care settings, diagnostic centers, ambulatory surgery centers (ASC) and hospitals & clinics, are some of the top end-users in the market. The leading spot has been procured by the hospitals and clinics segment, which touched USD 1,740.0 Million in 2018.

Arrhythmia Monitoring Devices Market Regional Status

Arrhythmia monitoring devices industry can be regionally divided into Europe, Asia Pacific (APAC), MEA or Middle East and Africa as well as the Americas.

America has emerged as the most profitable market, on account of the easy availability of highly innovative and effective options for arrhythmia, such as artificial pacemakers, antiarrhythmic drugs and implanted defibrillators. The region’s favorable reimbursement policies and the vast pool of renowned firms that spend significantly on rigorous R&D activities also enhance the market share.

Europe is currently the second most lucrative market, given that the adoption rate of cardiac arrhythmia monitors in the region is significantly high in line with the escalating cases of cardiac disorders. In 2018, the lead was taken by Spain in the region, accounting for a share of 5.5% in view of the surging use of smartphone applications bridging the communication gap between patients and doctors. Moreover, with clinics and hospitals striving to include arrhythmia care in routine treatment procedures, the European market is bound to fare well in the years to come.

Asia Pacific should progress at the fastest rate in the following years, as a result of the exploding population and the continuous surge in the use of latest technologies like wearables such as fitness monitors, mobile monitoring systems and fabric monitoring systems. Soaring preference for compact, home‐based, and portable monitoring devices along with the improving reimbursement scenario will also benefit the APAC market in subsequent years.

Browse Full Report with TOC at:

Arrhythmia Monitoring Devices Market Prominent Contenders

Some of the affluent firms analyzed in the MRFR market study are Spacelabs Healthcare (US), Biotronik (Germany), Abbott Laboratories (US), Medtronic plc (Ireland), Alive Cor, Inc. (US), BioTelemetry, Inc. (US), Fukuda Denshi Co. Ltd (Japan), Applied Cardiac Systems Inc. (US), Nihon Kohden Corporation (Japan), GE Healthcare (US), and more.

Endoscopy Device Market Prevalent Opportunities up to 2027

Endoscopy Device Market Insight

Global endoscopy devices market is expected to exhibit a strong 6.3% CAGR over the forecast period from 2017 to 2023, according to the latest research report from Market Research Future (MRFR). The global endoscopy devices market is profiled in detail in the report, providing detailed information on the market’s past, present, and future. Studied forecasts for the market’s growth over the forecast period are made in the report on the basis of a comprehensive study of the market’s past growth trajectory. Detailed information is also provided on the market’s leading drivers and restraints, allowing the reader to get a clear idea of the economic environment of the market.

Endoscopy devices are a special class of medical devices used to carry out internal examination or surgical procedures inside the body. An endoscope can be inserted into the body for the purpose of examining internal organs or for carrying out minor surgical procedures. The growing demand for screening and diagnosis of colorectal cancer is likely to be a major driver for the global endoscopy devices market over the forecast period. The prevalence of colorectal cancer has grown steadily over the last few years due to changes in the lifestyle and diets, leading to a growing demand for screening for the same. Colorectal cancer has quickly become one of the leading types of cancer all over the world, leading to a growing demand for screening and diagnostic procedures. The growing geriatric population around the world has also played a role in the increasing prevalence of colorectal cancer, as most colorectal cancer cases are detected in people aged 50 or more.

Endoscopy Device Market Competitive Analysis:

Leading players in the global endoscopy devices market include Richard Wolf, Pentax Medical, Fujifilm, Karl Storz GmbH & Co. KG, Olympus, Stryker Corporation, Cognetix, Micro-Tech Endoscopy, Cantel Medical, Interscope Inc., Shaili Endoscopy, J&J Services Inc., Integrate Endoscopy, and Cogentix Medical. Leading players in the endoscopy devices market are likely to focus on product development in the coming years in order to produce more capable and functional endoscopes.

Get customized Sample with complete Toc, Inclusive of COVID-19 Industry Analysis @

Endoscopy Device Market Segmentation:

The global endoscopy device market is segmented on the basis of types, therapy, treatments & procedures, application, accessory & processors, technology, end user, and region.

On the basis of type, the global endoscopy device market is segmented into flexible endoscopes, rigid endoscopes, capsule endoscopes, surgical endoscopes, and robot-assisted endoscopes.

On the basis of therapy, the market is segmented into colonoscopy, gastroscopy, arthroscopy, laparoscopy, sigmoidoscopy, endoscopic retrograde cholangiopancreotography, ureteroscopy, and cystoscopy.

On the basis of treatments & procedures, it is segmented into abdominal, gynecologic and pelvic organ conditions, joint and orthopedic conditions, lower gastrointestinal conditions, lung and airway conditions, upper gastrointestinal conditions, and urinary system conditions. The abdominal, gynecological, and pelvic organ conditions segment is further segmented into hernia repair, removal of the appendix, gallbladder, spleen, uterine fibroids, endometrial tissue, and ectopic pregnancy. The joint and orthopedic conditions segment is further segmented into repair of rotator cuff conditions, carpal tunnel syndrome, loose bone or cartilage, torn or damaged cartilage, tendons, and arthritis. The lower gastrointestinal conditions segment is further segmented into removal of colon polyps and treatment of bleeding from the colon. Lung and airway conditions are further segmented into lung abscess, removal of a foreign object in the airway, and opening of a narrowed airway. The upper gastrointestinal conditions segment is further segmented into removal of polyps and foreign objects, widening of a narrowed esophagus, treatment of hypertensive lower esophageal sphincter, Barrett’s esophagus, and esophageal cancer.

On the basis of applications, the endoscopy device market is segmented into gastrointestinal endoscopy, arthroscopy, obstetrics/gynecology endoscopy, urology endoscopy, bronchoscopy, mediastinoscopy, and otoscopy.

On the basis of accessory & processors, the market is segmented into accessory and processors.

On the basis of technology, the endoscopy devices market is segmented into video and fiber.

On the basis of end user, the market is segmented into critical care, gastroenterologists, general and pediatric surgeons, obstetricians-gynecologists (ob/gyns), and orthopedic surgeons.

Get Premium Research Report, Inclusive of COVID-19 Impact Analysis, Find more information @

Endoscopy Device Market Regional Analysis:

The Americas hold the largest share in the global endoscopy devices market; the market in this region is expected to reach a valuation of USD 15,186.1 million by 2023. On the other hand, Asia Pacific is the fastest growing market and is expected to exhibit a robust 6.8% CAGR over the forecast period from 2017 to 2023.

Beauty Devices Market to Observe Strong Development by 2027

Beauty Devices Market Overview

Beauty devices have come ridiculously close to making the youthful skin a reality. Just a few years ago, the beauty treatments were sinfully expensive and highly specialized. Consumers had to either visit a dermatologist, plastic surgeon, or an esthetician to get the appropriate procedures to correct or manage their beauty concerns.

While some conditions and desired results would still demand a trip to professional, technological advancements in beauty devices have been exploding, and there are now a variety of options to treat head to toe beauty related concerns. As a result, the beauty devices market is growing radically heading with a wide range of varieties enabled with varying technologies.

The market growth of beauty devices is a little overwhelming to weed through. Acknowledging the phenomenal upsurges, the market is witnessing and gauging the potential of the market to go further in the years to come, Market Research Future (MRFR) in its recently published study report asserts that the global beauty devices market will grow exponentially, registering a CAGR 7.8 during the period (2017 -2023). 

In addition to the rapid urbanization, increased disposable income and better living standards along with the strong desire among consumers to look and feel young & beautiful are driving the growth of the beauty devices market. Moreover, rising prevalence of skin diseases such as wrinkles, acne, melisma (photoaging of skin) associated with excessive exposure to ultraviolet radiation and pollution, are contributing to the elevated growth of the beauty devices market, resulting in sunburns, reduced skin elasticity, and hair loss.

Additionally, the benefits obtained by the beauty devices are considered as one of the major driving forces. Simultaneously, the growing reach of the media has allowed manufacturers to expand their range and minimize recall value by offering a product suiting to consumer’s budget, body, skin, complexion type, and the environment. Furthermore, the growing requirement for brand differentiation in an increasingly competitive environment is expected to foster the market growth.

On the other hand, factors such as disadvantages or side effects such as discomfort, excessive swelling, and sensitive skin, bruising, and blistering, associated with the mishandling or wrong application of these devices, alongside some of the prevailing side effects occurring post-treatment are impeding the market growth. Besides, some devices belch intense pulsed light which can trigger the side effects, such as scarring, superficial burns, edema, and postoperative erythema may hinder with the growth of beauty devices market. 

Global Beauty Devices Market   – Segmentation

MRFR has segmented its analysis into five key dynamics for the convenience of understanding; 

By Technologies    : Comprises – Transcutaneous electrical nerve stimulation (TENS) technology, Wearable Devices, Lasers Invigorate  and others.

By Types                  : Hair Growth Devices, Acne Removal Devices, Rejuvenation Devices, Skin Derma Rollers & Hair Removal Devices, Cleansing Devices, Oxygen, Steamer Devices, Light/LED Therapy & Photo Rejuvenation Devices, and Cellulite Reduction Devices among others.

By Applications     : Instrumental Cosmetics, and Ultrasonic Infuser among others.

By End-User            : Professional (Spas, Salons, Clinic and others), and Personalized (At home) among others.

By Regions               : North America, APAC, Europe, and Rest-of-the-World. 

Global Beauty Devices Market   – Regional Analysis 

The North American is the leading market for beauty devices, globally, holding the largest market share owing to the technological advancement in beauty devices. Owing to the factors such as the well-developed technology, increasing patient with PCOS, rising aging population, and growing government support for research & development, the region is expected to further continue with its dominance in the future. Furthermore, increased R&D activities and the presence of major companies are fostering the market growth in the region.

The European region stands at the second position in terms of the market size of beauty devices owing to the government support for R&D and availability of funds for research. Germany among other European countries, backed by its expertise in medical devices market will support the market growth in the region to grow at a much higher rate than the industry average.

The APAC region has emerged as a promising market for beauty devices owing to the presence of rapidly developing healthcare technology and improving economic conditions in the region. The devices market in the APAC region projects a high growth rate in the years to come owing to the plentiful new product launches. High returns are rewarded to the majority of at-home beauty device firms that had the foresight to enter Asian beauty devices market. India and China among other APAC countries are anticipated to grow rapidly, commanding significant market shares. The beauty and personal care market in Japan, China, and Korea are also growing owing to the rapid economic development in these countries. 

Global Beauty Devices Market   – Competitive Analysis

The highly competitive, beauty devices market appears fragmented due to the presence of many well-established players having the global presence.

M&A activities, innovation, brand reinforcement, and collaboration remain the key trends for these players.  Manufacturers are striving to develop high-performance beauty devices powered by the latest technology and clinical advances.

Browse Full Report with TOC at:

Beauty Devices Market Key Players:

Leaders in the global beauty devices market include Nu Skin Enterprises, L’Oreal S.A., Panasonic Corporation, Home Skinovations Ltd, Syneron Medical Ltd, TRIA Beauty Inc, PhotoMedex Inc, Procter & Gamble Co, Home SKinovations Ltd, Photomedax Inc., Lumenis Ltd., Carol Cole Company, Koninklijke Philips N.V., and Tria Beauty Inc.

Cell Culture Media Market to Witness Increase in Revenues by 2027

Cell Culture Media Market Dynamics

According to the latest report furnished by Market Research Future (MRFR), the cell culture market is exhibited to develop at a robust CAGR of 9.1% during the forecast period (2017-2023).

Growth Drivers and Key Challenges

Cell culture medium consists of a number of nutrients that promote the proliferation, growth, storage and maintenance of microorganisms as well as other types of cells including mammalian, stem cells, and other cell lines. There is a diverse range of culture media available in the international market for different cell cultures for surviving and growing in their incubation environment.

The cell culture media market will also be positively affected by factors like the increasing investments as well as funding for research and development (R&D) along with innovations in life sciences, particularly the biopharmaceutical products. On top of this, the expansion of the biosimilar industry at a substantial rate is a primary contributory factor backing the growth of the cell culture media market.

Despite the presence of favorable drivers, the dearth of skilled professionals could give a major blow to the growth of the market. On the contrary, the developing markets like India and China are projected to present various lucrative growth opportunities to the global market in the forthcoming years.

Cell Culture Media Market Segmentation

The cell culture media market has been segmented on the basis of type, application, and end-user.

Considering the type, the cell culture media market has been broken down into classical media, chemically defined media, protein-free media, lysogeny broth, serum-free media, and custom media. Among these, lysogeny broth happens to be the shareholder of the larger share of the overall market, amounting to 22.5% of the total market. On the other hand, the chemically defined media is exhibited to register the fastest growth rate of 9.6% during the evaluation time frame.

Application-wise, the cell culture media market covers segments like tissue engineering & biochemistry, cancer research, toxicity testing, drug discovery and drug development, genetic engineering, and stem cell research. Accruing almost 23.8% of the overall market share, the drug discovery and drug development segment is having a relentless run in the international market.

The end-users mentioned in the report include research laboratories, academic institutes, biotechnology & pharmaceutical companies, and pathology labs, where the biotechnology & pharmaceutical companies are expected to the dominating market, with its value being around USD 386.5 million in 2016.

Cell Culture Media Market Regional Analysis

In terms of the geographical distribution of the global cell culture media market, the key regions covered by the report are the Americas, Europe, Asia Pacific (APAC), and the Middle East and Africa (MEA).

Leading with the biggest share in the global cell culture media market, the Americas is profiting from the presence of superlative infrastructure, growing integration of cutting-edge developments in practice, and the technological brilliance within the region. The vast pool of patients provides immense traction to the regional market as well, coupled with the increasing number of research and development activities. These research and development projects are associated with cytological analysis of genomics, drug and vaccine development as well as proteomics.

Europe is making similar strides in the global market as well, resulting from the rise in R&D investments, surge in the advancements related to cell culture media, and strong demand for cell culture media. Other factors that facilitate the growth of the market include the advancement of animal-component free media along with the presence of automated cell culture systems that help decrease the lag times, in addition to improving the production capacity of the complete project. Data analysis predict that the demand for cell culture techniques will increase within the region in the years ahead.

In the meantime, Asia Pacific is another region making its presence felt in the worldwide market, surging at the fastest growth rate. The market owes its phenomenal growth to factors like the rising number of contract manufacturing as well as the outsourcing of cell culture technology. The hike in the demand for cell culture medias paired with the growth in the biopharmaceutical research has resulted in the favorable expansion of the regional market in the past couple of years.

Cell Culture Media Market Top Vendors

The top vendors in the global cell culture media market are BD Biosciences (U.S.), HiMedia Laboratories (India), Corning Incorporated (U.S.), Thermo Fisher Scientific (U.S.), GE Healthcare (U.S.), Merck KGaA (Germany), Lonza (Switzerland), and others.

Browse Full Report with TOC at:

Cell Culture Media Market Recent Developments

May 2019

CN Bio has announced the development of a 3D cell culture system known as PhysioMimix. This lets the researchers layout assays, in addition to getting results at a faster rate. PhysioMimix will ensure that the scientists are able to mimic the structure as well as the function of human organs in the experiments being conducted in the future.

Contract Research Organization (CRO) Market By Global Industry Analysis, Segments, Top Key Players, Drivers and Trends

Contract Research Organization (CRO) Market Overview

The Global Contract Research Organization (CRO) Market is poised to grow at a CAGR of 11.48% during the forecast period and acquire a significant valuation.

Contract Research Organization (CRO) Market Dynamics

As the economy has changed, some medical firms have outsourced certain vital facets of their activities to overseas hospitals. The favourable conditions for the production of CROs have contributed to the successes of many CROs. Contract research companies benefit from economies of scale in which they can deliver cheaper costs to customers. The advent of new strategies for battling cancer has caused businesses to take advantage of advanced needs. The benefits from lower prices, then, will be carried on to the final customer, making life easy on the pocketbook. And thus, the factors of economies of scale, mutual benefit and emphasis on core competencies will drive potential growth of the industry.

R&D outsourcing would grow incrementally in both pre-clinical and clinical testing fields. The specialist design of this section, combined with the ever-tightening rules, is why the change is occurring. The high costs of clinical trials, and the cost savings by contracting out of clinical studies is another explanation for the need to subcontract clinical studies. Another explanation is that relationships between supply chains and risk control are becoming increasingly critical. Thus contracting out is done in part to boost output, increase productivity, speed production, and so on. It has thus become crucial to retain a strategic edge in today’s cut throat industry. The rising need in the pharmaceutical industry for research on cancer has driven businesses to outsource its specialist needs.

However, the contract analysis company market can be constrained by the high cost of labor and technological shifts in the sector, and other factors. In tandem with the fear of losing crucial in-house analysis skills, the high valuation of intellectual property associated with contracting research is contracting the industry. 

Contract Research Organization (CRO) Market Segmental Analysis

The global contract research organization (CRO) market is segmented on the basis of clinical trial phase, segment, and end users.

On the basis of segment, the market is segmented drug discovery, post marketing services, clinical development, and others.

On the basis of clinical trial, the market is categorised into phase I, phase II, phase III, phase IV, preclinical trials, and others.

On the basis of end users, the contract research organization market is segmented into medical devices companies, pharmaceutical/ biotechnology companies, academic institutes and others.

Contract Research Organization (CRO) Market Regional Overview

The Americas leads the global contract research company (CRO) industry because of a broad healthcare system that is well-developed and provides enough patients. However, changing lifestyle and related healthcare spending have played an important role in the growth of the sector. The proximity of developing economies such as the US and Canada would only enhance the business development in this area.

Second in global market share is Europe, followed by Asia Pacific. The availability of funds for research, a massive patient demographic, high healthcare costs, and government funding are expected to fuel the development of health business over the next few years. Europe was first split into Western and Eastern divisions. Western Europe was primarily responsible for the EU regional market, with most of the revenues originating from Germany, the United Kingdom, and France. However, Eastern Europe has the highest promise in terms of future development because it has the biggest untapped sector.

Owing to the prevalence of a large patient population, Asia Pacific is the fastest-growing region in the global market for contract research organizations, continually evolving economies such as India and China that have emerging healthcare per capita income. the Indian health care market is a rapidly-growing industry and is projected to progress at a CAGR of 22.87% over the next five years. Additionally, favorable government legislation drive the development of this sector.

In comparison to the developing countries, the Middle East & Africa has the least share in the global contract research organization market due to weak infrastructure and economic factors. The Middle East region retains the bulk of the business due to its well-established healthcare system and also due to the presence of developed economies of Saudi Arabia, Dubai, and Kuwait.

Browse Full Report with TOC at:

Contract Research Organization (CRO) Market Competitive Landscape

The major players for the Global Contract Research Organization Market are  PAREXEL International Corporation. (U.S.), QuintilesIMS (U.S.), Laboratory Corporation of America Holdings. (U.S.), Pharmaceutical Product Development, LLC. (U.S.), INC Research LLC (U.S.), PRA Health Sciences, Inc. (U.S.), ICON plc. (Europe) and others.

Create your website with
Get started